Surgalign Holdings Inc (SRGA) is trading 47% higher at $5.87 today.
- Scheduled to announce Q2 earnings results on Tuesday, August 9th, after market close
- Consensus EPS Estimate: -$2.25 (vs. -$0.09 in Q2/2021)
- Consensus Revenue Estimate: $21.13M (-14.9% Y/Y)
- Over the last 90 days, analysts have made 1 upward EPS revision and 0 downward
Surgalign Holdings Inc has been trading between a 52-week high of $48.6 and a 52-week low of $2.95. The stock has a market cap of $1.17 Billion.
Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes.
Headlines
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Benzinga 08-09-22